These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17826224)

  • 1. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
    Mak RH; Cheung WW; Roberts CT
    Growth Horm IGF Res; 2008 Feb; 18(1):17-25. PubMed ID: 17826224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone axis in chronic kidney disease.
    Mahesh S; Kaskel F
    Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men.
    Marcell TJ; Harman SM; Urban RJ; Metz DD; Rodgers BD; Blackman MR
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1159-64. PubMed ID: 11701429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH/IGF-1 signaling.
    Farquharson C; Ahmed SF
    Pediatr Nephrol; 2013 Apr; 28(4):547-56. PubMed ID: 22886280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth.
    Pass C; MacRae VE; Ahmed SF; Farquharson C
    Cell Biochem Funct; 2009 Apr; 27(3):119-27. PubMed ID: 19330796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease.
    Brown DD; Dauber A
    Horm Res Paediatr; 2021; 94(3-4):105-114. PubMed ID: 34256372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone and IGF1 Actions in Kidney Development and Function.
    Gurevich E; Segev Y; Landau D
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myostatin is a skeletal muscle target of growth hormone anabolic action.
    Liu W; Thomas SG; Asa SL; Gonzalez-Cadavid N; Bhasin S; Ezzat S
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5490-6. PubMed ID: 14602795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and insulin-like growth factor-I axis in type 1 diabetes.
    Nambam B; Schatz D
    Growth Horm IGF Res; 2018 Feb; 38():49-52. PubMed ID: 29249623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy.
    Piccioli L; Arcopinto M; Salzano A; D'Assante R; Schiavo A; Stagnaro FM; Lombardi A; Panicara V; Valente P; Vitale G; Sarullo FM; Giallauria F; Marra AM
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):975. PubMed ID: 30183158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A; Lang CH; Wilson TA
    Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on new therapeutic options for the somatopause.
    Ceda GP; Dall'Aglio E; Morganti S; Denti L; Maggio M; Lauretani F; Andrea A; Ceresini G; Cattabiani C; Valenti G
    Acta Biomed; 2010; 81 Suppl 1():67-72. PubMed ID: 20518193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a link between IGF-I and cancer.
    Jenkins PJ; Bustin SA
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S17-22. PubMed ID: 15339239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology.
    Jensen EA; Young JA; Mathes SC; List EO; Carroll RK; Kuhn J; Onusko M; Kopchick JJ; Murphy ER; Berryman DE
    Growth Horm IGF Res; 2020; 53-54():101333. PubMed ID: 32717585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of growth hormone hypersecretion on the adult human kidney.
    Grunenwald S; Tack I; Chauveau D; Bennet A; Caron P
    Ann Endocrinol (Paris); 2011 Dec; 72(6):485-95. PubMed ID: 22098791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age.
    Huang Y; Du M; Zhuang S; Shen Z; Li Y
    Horm Res Paediatr; 2010; 74(2):106-13. PubMed ID: 20395663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.